Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Leduc

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Family Practice|October 1, 1988
A psychosocial description of a select group of infertile couplesD A Sahaj, C K Smith, K L Kimmel, et al.
Oncology|July 4, 2006
Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trialM Ducreux, O Bouche, J P Pignon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 28, 2012
[Magnetic resonance imaging for delineation of prostate in radiotherapy: monocentric experience and review of literature]P Auberdiac, C Chargari, F Négrier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2006
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trialJ-M Ferrero, B Weber, J-F Geay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO groupS Camilleri-Broët, A C Hardy-Bessard, A Le Tourneau, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Seminars in Oncology|November 5, 1997
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II studyE Pujade-Lauraine, J P Guastalla, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II studyJ P Guastalla, E Pujade-Lauraine, B Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast GroupT Delozier, M Spielmann, J Macé-Lesec'h, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Family Practice|October 1, 1988
A psychosocial description of a select group of infertile couplesD A Sahaj, C K Smith, K L Kimmel, et al.
Oncology|July 4, 2006
Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trialM Ducreux, O Bouche, J P Pignon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 28, 2012
[Magnetic resonance imaging for delineation of prostate in radiotherapy: monocentric experience and review of literature]P Auberdiac, C Chargari, F Négrier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2006
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trialJ-M Ferrero, B Weber, J-F Geay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO groupS Camilleri-Broët, A C Hardy-Bessard, A Le Tourneau, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Seminars in Oncology|November 5, 1997
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II studyE Pujade-Lauraine, J P Guastalla, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II studyJ P Guastalla, E Pujade-Lauraine, B Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast GroupT Delozier, M Spielmann, J Macé-Lesec'h, et al.
Pageof 6